THE EFFECT OF VIRTUAL REALITY APPLICATIONS ON SITTING BALANCE IN HEMIPLEGIA: A RANDOMIZED CONTROLLED STUDY
Launched by GAZIOSMANPASA RESEARCH AND EDUCATION HOSPITAL · May 15, 2024
Trial Information
Current as of February 08, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how virtual reality (VR) applications can help improve sitting balance and overall quality of life for people with hemiplegia, which is a condition that affects movement on one side of the body, often due to a stroke. The study aims to see if using VR can make it easier for patients to sit up straight without support. The trial is currently recruiting participants aged 65 to 74 who are at least 18 years old and have had a stroke within the last 1 to 18 months. They should also be able to sit for 2 minutes with some supervision.
Participants in this study can expect to engage with VR technology as part of their treatment. To be eligible, they need to have a stable medical condition and demonstrate a certain level of sitting balance. However, those with a history of stroke, communication difficulties, or other serious medical issues may not qualify. This is a great opportunity for eligible patients to explore an innovative approach to improving their balance and daily function.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Stable medical condition 2. Over 18 years of age 3. A score of 23 or above on the mini mental state test (MMDT) or the mini mental state test for the untrained (MMDT-E) 4. Within the period of 1-18 months after stroke 5. A score of 3 or 4 on the 3rd item of the Berg Balance Scale (BBS), which evaluates the balance of sitting without support (3= can sit for 2 minutes under supervision, 4= can sit safely for 2 minutes).
- Exclusion Criteria:
- • 1. Previous history of stroke 2. Aphasic patients in whom information exchange is not possible 3. Patients with impaired vision, hearing and vestibular system 4. Musculoskeletal and nervous system disorders other than stroke that may cause physical disability 5. Patients with a history of epilepsy 6. Cerebrovascular attack involving more than one hemisphere 7. Presence of cerebellar lesions or impaired cerebellar tests
About Gaziosmanpasa Research And Education Hospital
Gaziosmanpasa Research and Education Hospital is a leading healthcare institution dedicated to advancing medical research and education. With a commitment to innovative clinical practices, the hospital serves as a hub for clinical trials aimed at improving patient outcomes and enhancing therapeutic options. The institution fosters collaboration among multidisciplinary teams, integrating cutting-edge research with exceptional patient care. By prioritizing ethical standards and regulatory compliance, Gaziosmanpasa Research and Education Hospital is poised to contribute significantly to the field of medical science and the development of new treatment modalities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, , Turkey
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0